BTAI:BioXcel Therapeutics Inc Snapshot | Charting | News | Options
$2.71 NASDAQ 6:59a ET
September 18 '25 		BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements
     GlobeNewswire
    Full Story →

    Headline News
    BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia
    6:30a ET September 10 '25 GlobeNewswire
    BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
    7:00a ET September 4 '25 GlobeNewswire
    UPDATE -- BioXcel Therapeutics Announces SERENITY At-Home Pivotal Phase 3 Safety Trial Met its Primary Endpoint in Support of sNDA Submission for Label Expansion of IGALMI(R)
    8:00a ET August 27 '25 GlobeNewswire
    More News →
    Day  3.90%Week  9.36%Month  31.57%More Charting →
    September 26 '25. Markets Closed.
    Last $2.71
    Day change   3.90%$0.11
    Open $2.96
    Gap at open $0.14
    Previous close $2.82
    Trading volume 1,241,062
    10 Day avg vol. 1,549,258
    Shares out. 19.6Mil
    Market cap. $53.2Mil
    Trading activity Below Avg.
    Previous data from yesterday, September 25 '25.

    Historical Price Performance
    3 month   53.11% 
    6 month   27.83% 
    1 year   68.30% 
    2 year   93.82% 

    Earnings
    Previous 12m -$13.38
    Next 12m Estimate -$5.31
    P/E ratio --
    Revenue 1Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2025 All rights reserved.